Publications

2025              Golan Y, Nyquist SK, Liu Z, Ennis D, Zhao J, Blair E, Khan AR, Prahl M, Gaw SL, Yassour M, Engelhardt BE, Flaherman VJ, Ahituv N. Genomic characterization of normal and aberrant human milk production. Science Advances. Sept 2025. doi: 10.1126/sciadv.adr7174

 

2025              Yin K, Li L, Luo X, Neidleman J, Cassidy AG, Golan Y, Ozarslan N, Yin CY, Jigmeddagva U, Illala M, Chidboy M, Prahl M, Gaw SL, Roan N. Pregnancy and Lactation induce distinct immune responses to COVID-19 booster vaccination and SARS-CoV-2 breakthrough infection. JCI Insight. 2025 Jul. doi:10.1172/jci.insight.191930 

 

2025              Blauvelt C, Zeme M, Natarajan A, Epstein A, Roh ME, Morales A, Bourdoud N, Flaherman V, Prahl M, Gaw SL. Respiratory Syncytial Virus Vaccine and Nirsevimab uptake among pregnant people and their neonates. JAMA Network Open. 2025 Feb 3;8(2):e2460735. doi: 10.1001/jamanetworkopen.2024.60735. PMID: 39969879

 

2025              Acevedo GR, Samiee SS, Ilala MS, Levan J, Olive ME, Hunter R, Prahl M, Rajalingam R, Rek J, Dorsey G, Feeney ME. Liver stage P. falciparum antigens highly targeted by CD4+ T cells in malaria-exposed Ugandan children. PLoS Pathogens. Feb 24;21(2):e1012943.doi:10.1371/journal.ppat.1012943. PMID: 39993000

 

2024             Jaswa E, Huddleston HG, Lindquist KJ, Wu AHB, Bishop SL, Kim YS, Kaing A, Prahl M, Gaw SL, Corley J, Hoskin E, Cho YJ, Rodgers EE, Cedars MI. In utero exposure to maternal COVID-19 infection and offspring neurodevelopment through age 24-months. June 2024. JAMA Network Open. 2024 Oct 1;7(10):e2439792. doi:10.1001/jamanetworkopen.2024.39792. PMID: 39412802 

 

2024              Li L*, Matsui Y*, Prahl MK, Cassidy AG, Golan Y, Jigmeddagva U, Ozarslan N, Lin CY, Buarpung S, Gonzalez VJ, Chidboy MA, Basilio E, Lynch KL, Song D, Jegatheesan P, Rai DS, Govindaswami B, Needens J, Rincon M, Myatt L, Taha TY, Montano M, Ott M, Greene WC, Gaw SL.  Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy. NPJ Vaccines. 2024 Aug 27;9(1):156. PMID: 39191763 PMCID: PMC11349990. doi: 10.1038/s41541-024-00948-3. 

 

2024              Jaswa EG, Cedars MI, Lindquist KJ, Bishop SL, Kim YS, Kaing A, Prahl M, Gaw SL, Corley J, Hoskin E, Cho YJ, Rogers E, Huddleston HG. In Utero Exposure to Maternal COVID-19 Vaccination and Offspring Neurodevelopment at 12 and 18 Months. JAMA Peds. 2024 Mar 1;178(3):258-265. PMID: 38252445. doi:10.1001/jamapediatrics.2023.5743.

 

2023              Golan Y, Illala M, Li L, Gay C, Hunagund S, Lin CY, Cassidy AG, Jigmeddagva U, Masui Y, Ozarslan N, Asiodu IV, Ahituv N, Flaherman VJ, Gaw SL*, Prahl M*. Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection. iScience. 2023 Aug 29;26(10):107767. PMID: 37731614. doi: 10.1016/j.isci.2023.107767

 

2023              Gonzalez V, Li L, Buarpung S, Prahl M, Robinson JF, Gaw SL. Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants. iScience. 2023 August7;26(9);107549. PMID 37664582 doi: 10.1016/j.isci.2023.107549

 

2023              Cassidy AG, Li L, Golan Y, Gay C, Lin CY, Jigmeddagva U, Chidboy MA, Ilala M, Buarpung S, Gonzalez VJ, Basilio E, Duck M, Murtha AP, Wu AHB, Lynch KL, Asiodu IV, Prahl M*, Gaw SL*. Assessment of Adverse Reactions, Antibody Trends, and 12-month Outcomes in the Mother-Infant Dyad after COVID-19 mRNA Vaccination in Pregnancy. JAMA Network Open. 2023 Jul 3;6(7) PMID: 37450302. doi: 10.1001/jamanetworkopen.2023.23405. 

 

2023              Lin CY, Cassidy AG, Li L, Prahl M, Golan Y, Gaw SL. Nirmatrelvir-Ritonavir (Paxlovid) for Mild Coronavirus Disease 2019 (COVID-19) in Pregnancy and Lactation. Obstet Gynecol. 2023 March 16. PMID: 36928334l. doi: 10.1097/AOG.0000000000005152

 

2022              Prahl M, Golan Y, Cassidy A, Matsui Y, Lin L, Alvarenga B, Chen H, Jigmeddagva U, Lin CY, Gonzalez VJ, Chidboy MA, Warrier L, Buarpung S, Murtha AP, Flaherman VJ, Greene WC, Wu AHB, Lynch KL, Rajan J, Gaw SL. Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancy. Nature Communications July. 2022 doi: 10.1038/s41467-022-32188-1, PMID: 35908075 PMCID: PMC9338928

 

2022              Matsui Y*, Li L*, Prahl M, Cassidy AG, Ozarslan N, Golan Y, Gonzalez VJ, Lin CY, Jigmeddagva U, Chidboy MA, Montano M, Taha TY, Khalid MM, Sreekumar B, Hayashi JM, Chen P, G. Kumar R, Warrier L, Wu AHB, Song D, Jegatheesan P, Rai DS, Govindaswami B, Needens J, Rincon M, Myatt L, Asiodu IV, Flaherman VJ, Afshar Y, Jacoby VL, Murtha AP, Robinson JF, Ott M,Greene WC, Gaw SL. Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads. JCI Insight. 2022 May 17;e157354.doi: 10.1172/jci.insight.157354. PMID: 35579965 

 

2022              Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Chakraborty S, Dubey M, Ashraf U Cheng BY, Kathale N, Thi Tran KQ, Scallan C, Sinnott A, Cassidy A, Chen ST, Gelbart T, Goa F, Golan Y, Ji X, Kim-Schulze S, Prahl M, Gaw SL, Gnjatic S, Marron TU, Merad M, Arunachalam PS, Boyd SD, Davis MM, Holubar M, Khosla C, Maecker HT, Maldonado Y, Mellins ED, Nadeau KC, Pulendran B, Singh U, Subramanian A, Utz PJ, Sherwood R, Zhang S, Jagannathan P, Tan GS, Wang TT. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Science Translational Medicine. 2022 Mar 9;14(635):eabm7853. doi: 10.1126/scitranslmed.abm7853.Epub 2022 Mar 9. PMID: 35040666. PMCID: PMC8939764

 

2022              Sievers BLChakraborty SXue YGelbart TGonzalez JCCassidy AGGolan YPrahl MGaw SLArunachalam PSBlish CABoyd SDDavis MMJagannathan PNadeau KCPulendran BSingh UScheuermann RHFrieman MHVashee SWang TTTan GS. Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Dec. 2021 Science Translational Medicine.  2022 Mar 2;14(634):eabn7842. doi:10.1126/scitranslmed.abn7842. PMID: 35025672. PMCID: PMC8891085

 

2022              Hunagund S, Golan Y, Asiodu IV, Prahl M, Gaw SL. Effects of vaccination against influenza, pertussis, and COVID-19 on human milk antibodies: current evidence and implications for health equity. Frontiers in Immunology. 2022 Jul 12;13:910383. PMID:35903100. doi: 10.3389/fimmu.2022.910383.

 

2022              Vaaben AV, Levan J, Nguyen CBT, Callaway PC, Prahl M, Warrier L, Nankya F, Musinguzi K, Kakuru A, Muhindo MK, Dorsey G, Kamya MR, Feeney ME. In utero activation of NK cells in congenital CMV infection. Journal of Infectious Disease. 2022 Sep 4;226(4):566-575.doi: 10.1093/infdis/jiac307. PMID: 35876164 PMCID: PMC9441208

 

2021              Golan Y, Prahl M, Cassidy AG, Gay C, Wu AHB, Jigmeddagva U, Lin CY, Gonzalez VJ, Basilio E, Warrier L, Buarpung S, Li L, Asiodu IV, Ahituv N, Flaherman VJ, Gaw SL. COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyads. Frontiers in Immunology. 2021 Nov 3;12:777103. doi: 10.3389/fimmu.2021.777103. PMID 34804068. PMCID: PMC8595828. 

 

2021              Song D, Prahl M, Gaw SL, Narasimhan SR, Rai DS, Huang A, Flores CV, Lin CY, Jigmeddagva U, Wu A, Warrier L, Levan J, Nguyen CBT, Callaway P, Farrington L, Acevedo GR, Gonzalez VJ, Vaaben A, Nguyen P, Atmosfera E, Marleau C, Anderson C, Misra S, Stemmle M, Cortes M, McAuley J, Metz N, Patel R, Nudelman M, Abraham S, Byrne J, Jegatheesan P. Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study. BMJ Open. 2021 07 07; 11(7):e053036. PMID: 34234001. PMCID: PMC8264915

 

2021              Golan Y, Prahl M, Cassidy A, Lin CY, Ahituv N, Flaherman VJ, Gaw SJ.

mRNAs from COVID-19 BTN162b2 and mRNA-1273 vaccines are not detected in human milk. JAMA Pediatrics. 2021 Oct 1;175(10):1069-1071.doi:110.1001/jamapediatrics.2021.1929. PMID: 34228115

 

2021              Simon N, Shallat J, Houck J, Jagannathan P, Prahl M, Muhindo MK, Kakuru A, Olwoch P, Feeney ME, Harrington WE. Peripheral Plasmodium falciparum infection in early pregnancy is associated with increased maternal microchimerism in the offspring. Journal of Infectious Disease. 2021 May 19;jiab275. PMID 34010401

 

2021              Prahl M, Odorizzi P, Gingrich D, Muhindo M, McIntyre T, Budker R, Jagannathan P, Farrington L, Nalubega M, Nankya F, Sikyomu E, Musinguzi K, Naluwu K, Auma A, Kakuru A, Kamya M.R., Dorsey G, Aweeka F, Feeney M.E. Exposure to pesticides in utero impacts fetal immune development and response to vaccination in infancy. Nature Communication. 2021 Jan 8;12(1):132. PMID 33420104. PMCID PMC7794579.

 

2020              Flaherman, VJ, Afshar, Y, Boscardin J, Keller RL, Mardy A, Prahl M, Phillips C, Asiodu IV, Berghella WV, Chambers BD, Crear-Perry J, Jamieson D, Jacoby VL, Gaw SL. Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study. Clinical Infectious Disease. 2020 Sep 18. PMID: 32947612

 

2020              Blauvelt CA, Chiu C, Donovan AL, Prahl M, Shimotake TK, George RB, Schwartz BS, Farooqi NA, Ali SS, Cassidy A, Gonzalez JM, Gaw SL. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient with Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2020 May 8. PMID: 32384385. 

 

2018              Odorizzi P, Jagannathan P, McIntyre T, Budker R, Prahl M, Auma A, Burt T, Nankya F, Nalubega M, Sikyomu E, Musinguzi K, Naluwu K, Kakuru A, Dorsey G, Kamya MR, Feeney ME. In utero priming of highly functional effector T cell responses to human malaria. Science Translational Medicine. 2018 Oct 17;10(463). PMID: 30333241

 

2018              Jagannathan P, Kakuru A, Okiring J, Muhindo MK, Natureeba P, Nakalembe M, Opira B, Olwoch P, Nankya F, Ssewanyana I, Tetteh K, Drakeley C, Beeson J, Reiling L, Clark TD, Rodriguez-Barraquer I, Greenhouse B, Wallender E, Aweeka F, Prahl M, Charlebois ED, Feeney ME, Havlir DV, Kamya MR, Dorsey G. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial. PLoS Med. 2018 Jul; 15(7): e1002606. PMID: 30016328. PMCID: PMC6049882

 

2017              Farrington L, Vance H, Rek J, Prahl M, Jagannathan P, Katureebe A, Arinaitwe E, Kamya MR, Dorsey G, Feeney ME. Both Inflammatory and regulatory cytokine responses are to malaria are blunted with increasing age in highly exposed children. Malaria Journal. 2017 Dec 29; 16 (1):499 PMID 29284469.

 

2017              Prahl M, Jagannathan P, McIntyre TI, Auma A, Wamala S, Nalubega M, Musinguzi K, Naluwu K, Sikyoma E, Budker R, Odorizzi P, Kakuru A, Havlir DV, Kamya MR, Dorsey G, Feeney ME. Sex disparity in cord blood FoxP3+ CD4 T regulatory cells in infants exposed to malaria in utero. OFID. 2017 Feb 11. (4) 1. PMID 28480292.

 

2016              Prahl M, Jagannathan P, McIntyre TI, Auma A, Farrington L, Wamala S, Nalubega M, MusinguziK, Naluwu K, Sikyoma E, Budker R, Vance H, Odorizzi P, Nayebare P, Ategeka J, Kakuru A, Havlir DV, Kamya MR, Dorsey G, Feeney ME. Timing of in utero malaria exposure influences fetal CD4 T cell regulatory vs. effector differentiation. Malaria Journal. 2016 Oct 7;15(1):497.PMID 27717402

 

2016              Prahl M, Dhaliwal G, Shulman S, Doshi N, Monash B. Another Spin Journal of Hospital Medicine. 2016 Jul;11(7):509-12. PMID 27018991 

 

2014              Prahl M, Smetana D, Porta N. Lactobezoar Formation in Two Premature Infants Receiving Medium-chain Triglyceride Formula. J Perinatol. 2014 Aug; 34(8):634-5 PMID: 25073493